Methylation of Cytosine Residues in DNA Controlled by a Drug Resistance Factor
AUTOR(ES)
Hattman, Stanley
RESUMO
The proportion of 5-methylcytosine (5MeCyt) and 6-methylaminopurine (N6-methyladenine, 6MeAde) in bacteriophage P22 DNA was analyzed as a function of the host-specificity the phage carried. In the DNA of P22 grown in strains harboring the modifying drug-resistance-transfer-factor N-3, the 5MeCyt content was at least twice that after growth in strains lacking the factor. In contrast, the 6MeAde level of P22 DNA was unaffected by the presence or absence of the factor. The 6MeAde and 5MeCyt levels were unaffected by factors 222 and N-1, which do not modify phage DNA.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=427572Documentos Relacionados
- Deoxyribonucleic acid-cytosine methylation by host- and plasmid-controlled enzymes.
- Methylation inhibitors can increase the rate of cytosine deamination by (cytosine-5)-DNA methyltransferase.
- Methylation of specific cytosine residues enhances simian virus 40 T-antigen binding to origin region DNA.
- Cytosine methylation enhances Z-DNA formation in vivo.
- Site-selective in vivo targeting of cytosine-5 DNA methylation by zinc-finger proteins